The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases
Authors
Keywords
Inflammatory diseases, Interleukin-17, Monoclonal antibody, Ixekizumab, Secukinumab, Brodalumab
Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 102, Issue -, Pages 108402
Publisher
Elsevier BV
Online
2021-12-01
DOI
10.1016/j.intimp.2021.108402
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL‐17A inhibitors in patients with chronic plaque psoriasis and history of malignancy: A case series with systematic literature review
- (2021) Francesco Bellinato et al. Dermatologic Therapy
- Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial
- (2021) James Cheng-Chung Wei et al. ANNALS OF THE RHEUMATIC DISEASES
- The risk of malignancy in secukinumab‐treated psoriasis, psoriatic arthritis and ankylosing spondylitis patients: analysis of up to five‐year clinical trial and post‐marketing surveillance data
- (2021) M. Lebwohl et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy and safety of interleukin‐17 inhibitors in the treatment of chronic rheumatic diseases: A combined and updated meta‐analysis
- (2021) Chongru He et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- IL17A/F nanobody sonelokimab in patients with plaque psoriasis: a multicentre, randomised, placebo-controlled, phase 2b study
- (2021) Kim A Papp et al. LANCET
- Depression and Obesity in Patients With Psoriasis and Psoriatic Arthritis: Is IL-17-Mediated Immune Dysregulation the Connecting Link?
- (2021) Efterpi Zafiriou et al. Frontiers in Immunology
- Secukinumab efficacy in patients with PsA is not dependent on patients’ body mass index
- (2020) Ilenia Pantano et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term effectiveness and safety of secukinumab for treatment of refractory mucosal and articular Behçet’s phenotype: a multicentre study
- (2020) Filippo Fagni et al. ANNALS OF THE RHEUMATIC DISEASES
- Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting
- (2020) Luca Navarini et al. CLINICAL RHEUMATOLOGY
- One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study
- (2020) Maria Sole Chimenti et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Tackling the autoimmune side in Spondyloarthritis: A systematic review
- (2020) Maria Sole Chimenti et al. AUTOIMMUNITY REVIEWS
- Depression in Psoriatic Arthritis: Dimensional Aspects and Link with Systemic Inflammation
- (2020) Ashish J. Mathew et al. Rheumatology and Therapy
- Brodalumab for the treatment of plaque psoriasis: up-to-date
- (2019) Kristen M. Beck et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Secukinumab: A Review in Ankylosing Spondylitis
- (2019) Hannah A. Blair DRUGS
- Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials
- (2019) Stefan Schreiber et al. ANNALS OF THE RHEUMATIC DISEASES
- Correction to: The pathogenicity of Th17 cells in autoimmune diseases
- (2019) Keiko Yasuda et al. Seminars in Immunopathology
- The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies
- (2019) Dennis G McGonagle et al. ANNALS OF THE RHEUMATIC DISEASES
- Short-Term Efficacy and Safety of IL-17, IL-12/23, and IL-23 Inhibitors Brodalumab, Secukinumab, Ixekizumab, Ustekinumab, Guselkumab, Tildrakizumab, and Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
- (2019) Fan Bai et al. Journal of Immunology Research
- Role of IL-17 in asthma pathogenesis and its implications for the clinic
- (2019) Rakhee K Ramakrishnan et al. Expert Review of Respiratory Medicine
- The role of interleukin-17 in tumor development and progression
- (2019) Junjie Zhao et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The safety of ixekizumab in psoriasis drug therapy
- (2019) Lluís Puig Expert Opinion On Drug Safety
- Interleukin-17 and lupus: enough to be a target? For which patients?
- (2019) M Robert et al. LUPUS
- IL-17A regulates the autophagic activity of osteoclast precursors through RANKL-JNK1 signaling during osteoclastogenesis in vitro
- (2018) Dianshan Ke et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database
- (2018) R. B. Warren et al. BRITISH JOURNAL OF DERMATOLOGY
- Effects of the IL-23–IL-17 pathway on bone in spondyloarthritis
- (2018) Ellen M. Gravallese et al. Nature Reviews Rheumatology
- Ixekizumab for the treatment of psoriasis: an update on new data since first approval
- (2018) Christoffer Blegvad et al. Expert Review of Clinical Immunology
- Ixekizumab (Interleukin 17A Antagonist): 12-week Efficacy and Safety Outcomes in Real-world Clinical Practice
- (2018) Jorge R. Georgakopoulos et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial
- (2018) Désirée van der Heijde et al. LANCET
- A safety assessment of biological therapies targeting the IL-23/IL-17 axis in inflammatory bowel diseases
- (2017) Bram Verstockt et al. Expert Opinion On Drug Safety
- CD49a Expression Defines Tissue-Resident CD8 + T Cells Poised for Cytotoxic Function in Human Skin
- (2017) Stanley Cheuk et al. IMMUNITY
- Secukinumab in the treatment of psoriasis: an update
- (2017) Radomir Reszke et al. Immunotherapy
- IL-17A enhances IL-13 activity by enhancing IL-13–induced signal transducer and activator of transcription 6 activation
- (2017) Sara L. Hall et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial
- (2017) Peter Nash et al. LANCET
- The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases
- (2017) Taku Kuwabara et al. MEDIATORS OF INFLAMMATION
- Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical Studies
- (2017) Christopher E.M. Griffiths et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Spotlight on brodalumab in the treatment of moderate-to-severe plaque psoriasis: design, development, and potential place in therapy
- (2017) Michael Roman et al. Drug Design Development and Therapy
- IL-17A Inhibits Osteogenic Differentiation of Bone Mesenchymal Stem Cells via Wnt Signaling Pathway
- (2017) Zhenguo Wang et al. MEDICAL SCIENCE MONITOR
- The Role of Th17 Cells in the Pathogenesis of Behcet’s Disease
- (2017) Yuki Nanke et al. Journal of Clinical Medicine
- Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis
- (2017) Jillian Frieder et al. Therapeutic Advances in Chronic Disease
- A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn’s Disease
- (2016) Stephan R Targan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Proinflammatory T cells and IL-17 stimulate osteoblast differentiation
- (2016) Michiel Croes et al. BONE
- Ixekizumab: First Global Approval
- (2016) Anthony Markham DRUGS
- Secukinumab: A Review in Psoriatic Arthritis
- (2016) Matt Shirley et al. DRUGS
- Safety of secukinumab in the treatment of psoriasis
- (2016) Andrew Blauvelt Expert Opinion On Drug Safety
- Roles of interleukin-17 in uveitis
- (2016) MartaCatarina Esteves Guedes et al. INDIAN JOURNAL OF OPHTHALMOLOGY
- Brodalumab, a human anti-interleukin-17-receptor antibody in the treatment of Japanese patients with moderate-to-severe plaque psoriasis: Efficacy and safety results from a phase II randomized controlled study
- (2016) Hidemi Nakagawa et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- IL-17-producing γδ T cells enhance bone regeneration
- (2016) Takehito Ono et al. Nature Communications
- Anti-IL-17 Medications Used in the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review
- (2015) Theresa N. Canavan et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis
- (2015) Francesco Ciccia et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-17 in systemic lupus erythematosus: A comprehensive review
- (2015) Duo Li et al. AUTOIMMUNITY
- Interleukin-17- and interleukin-22-secreting myelin-specific CD4+T cells resistant to corticoids are related with active brain lesions in multiple sclerosis patients
- (2015) Ana Cristina Wing et al. IMMUNOLOGY
- The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: Interleukin-17A and interleukin-17F serum levels
- (2015) Zohreh Babaloo et al. IMMUNOLOGY LETTERS
- Use of brodalumab for the treatment of psoriasis and psoriatic arthritis
- (2015) Dario N Kivelevitch et al. Immunotherapy
- T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity
- (2015) Vaishali R. Moulton et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
- (2015) Seth B. Coffelt et al. NATURE
- Basic biology and role of interleukin-17 in immunity and inflammation
- (2015) Camille Zenobia et al. PERIODONTOLOGY 2000
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- T helper 17 cells play a critical pathogenic role in lung cancer
- (2014) S. H. Chang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-17-producing CD4+ T cells are increased in early, active axial spondyloarthritis including patients without imaging abnormalities
- (2014) D. T. S. L. Jansen et al. RHEUMATOLOGY
- Body weight, gender and response to TNF- blockers in axial spondyloarthritis
- (2014) E. Gremese et al. RHEUMATOLOGY
- T lymphocyte subset imbalances in patients contribute to ankylosing spondylitis
- (2014) CHENGGONG WANG et al. Experimental and Therapeutic Medicine
- Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti–IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma
- (2013) William W. Busse et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- IL-17 protects T cells from apoptosis and contributes to development of ALPS-like phenotypes
- (2013) E. Boggio et al. BLOOD
- Antidrug antibodies in psoriasis: a systematic review
- (2013) L. Hsu et al. BRITISH JOURNAL OF DERMATOLOGY
- Elevated Serum Levels of Interleukin-17A in Uveitis Patients
- (2013) Shayma Jawad et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Secukinumab in the Treatment of Noninfectious Uveitis: Results of Three Randomized, Controlled Clinical Trials
- (2013) Andrew D. Dick et al. OPHTHALMOLOGY
- A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis
- (2013) David A Martin et al. ARTHRITIS RESEARCH & THERAPY
- ACR Meeting
- (2012) ARTHRITIS AND RHEUMATISM
- Role of IL-17 in Psoriasis and Psoriatic Arthritis
- (2012) Siba P. Raychaudhuri CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings
- (2012) David A. Martin et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- In Vivo Peripheral Blood Proinflammatory T Cells in Patients with Ankylosing Spondylitis
- (2012) L. LIMON-CAMACHO et al. JOURNAL OF RHEUMATOLOGY
- Enriched CD161highCCR6+γδ T Cells in the Cerebrospinal Fluid of Patients With Multiple Sclerosis
- (2012) Lucas Schirmer et al. JAMA Neurology
- TH17 Cells in Autoimmunity and Immunodeficiency: Protective or Pathogenic?
- (2012) Ashish K. Marwaha et al. Frontiers in Immunology
- New Interleukin-23 Pathway Inhibitors in Dermatology
- (2011) Marta Kurzeja et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Analysis of Proinflammatory and Anti-Inflammatory Cytokine Serum Concentrations in Patients With Multiple Sclerosis by Using a Multiplexed Immunoassay
- (2011) Thomas B. Martins et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- IL-17-producing invariant NKT cells in lymphoid organs are recent thymic emigrants identified by neuropilin-1 expression
- (2011) P. Milpied et al. BLOOD
- Spondyloarthritis
- (2011) Maxime Dougados et al. LANCET
- IL-17-producing T cells in lupus nephritis
- (2011) SA Apostolidis et al. LUPUS
- Dectin-2 Recognition of α-Mannans and Induction of Th17 Cell Differentiation Is Essential for Host Defense against Candida albicans
- (2010) Shinobu Saijo et al. IMMUNITY
- IL-17 in Systemic Lupus Erythematosus
- (2010) José C. Crispín et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice
- (2010) John S. Cho et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-17 Promotes Tumor Development through the Induction of Tumor Promoting Microenvironments at Tumor Sites and Myeloid-Derived Suppressor Cells
- (2010) Donggou He et al. JOURNAL OF IMMUNOLOGY
- Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis
- (2010) Andrea Chiricozzi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
- (2010) W. Hueber et al. Science Translational Medicine
- Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis
- (2009) Hui Shen et al. ARTHRITIS AND RHEUMATISM
- Cellular mechanisms of IL-17-induced blood-brain barrier disruption
- (2009) Jula Huppert et al. FASEB JOURNAL
- Differential Roles of Interleukin-17A and -17F in Host Defense against Mucoepithelial Bacterial Infection and Allergic Responses
- (2009) Harumichi Ishigame et al. IMMUNITY
- Interleukin-17-Producing γδ T Cells Selectively Expand in Response to Pathogen Products and Environmental Signals
- (2009) Bruno Martin et al. IMMUNITY
- Interleukin-1 and IL-23 Induce Innate IL-17 Production from γδ T Cells, Amplifying Th17 Responses and Autoimmunity
- (2009) Caroline E. Sutton et al. IMMUNITY
- TH17-associated cytokines (IL-17A and IL-17F) in severe asthma
- (2009) Wisam Al-Ramli et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-23 Is Required for Protection against Systemic Infection with Listeria monocytogenes
- (2009) K. D. Meeks et al. JOURNAL OF IMMUNOLOGY
- Genome-Wide Comparison between IL-17A- and IL-17F-Induced Effects in Human Rheumatoid Arthritis Synoviocytes
- (2009) S. Zrioual et al. JOURNAL OF IMMUNOLOGY
- Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17
- (2008) Muriel Pichavant et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome
- (2008) Joshua D. Milner et al. NATURE
- Simian immunodeficiency virus–induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut
- (2008) Manuela Raffatellu et al. NATURE MEDICINE
- IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia
- (2008) Shean J Aujla et al. NATURE MEDICINE
- Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis
- (2007) John S. Tzartos et al. AMERICAN JOURNAL OF PATHOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now